Business
CSL (ASX:CSL) share price on watch after hints of ‘far more robust’ vaccine – The Motley Fool Australia
Australian global biotech giant, CSL Limited didn’t win the sprint for a coronavirus vaccine. But it may lead the marathon.
The CSL Limited(ASX: CSL) share price is edging higher today, up 0.2% in afternoon trading.
That’s broadly in line with the wider S&P/ASX 200 Index (ASX: XJO), up 0.4% at time of writing.
With a history of generally delivering fairly steady share price growth, 2020 has been unusually volatile for CSL shareholders. While there are various reasons for this, traders jumping in and out of shares based on the latest COVID-19 vaccine news have certainly helped stir this year’s share price volatility.
…
-
Noosa News15 hours agoSunshine Coast locals raise $24,000 to rescue children from trafficking
-
Noosa News15 hours agoJack Steele stunned by how many Noosa kids are riding $3000 e-bikes
-
Noosa News24 hours agoLife sentence for tenant who murdered landlady in drunken rage
-
General18 hours agoCarney cautious after reports of Canada-US trade deal